Regular Article
Induction of Heat Shock Proteins by Tyrosine Kinase Inhibitors in Rat Cardiomyocytes and Myogenic Cells Confers Protection Against Simulated Ischemia

https://doi.org/10.1006/jmcc.1997.0431Get rights and content

Abstract

Previous studies have shown that in rodent myogenic cells and in the hearts of transgenic mice in which heat shock protein expression is increased there is a marked tolerance to ischemic/reperfusion injury. Furthermore, a recent study has shown that the benzoquinoid ansamycin antibiotic and tyrosine kinase inhibitor, herbimycin A, is capable of inducing the expression of heat shock proteins in fibroblasts. Our intention, in the present study, was to investigate if exposure of rat cardiomyocytes and the myogenic cell line H9c2 to herbimycin A would induce these proteins and, thus, confer protection against ischemic stress. For this purpose, we exposed both rat neonatal cardiomyocytes and H9c2 cells to herbimycin A and another related benzoquinoid ansamycin antibiotic, geldanamycin. We found that cells exposed to these compounds overexpressed heat shock proteins and are also rendered more tolerant to simulated ischemia as measured by the release of cytoplasmic enzymes. In addition, we found that the mechanism of induction of heat shock proteins by these compounds is similar, if not identical, to that of a heat shock (42°C, 60 min). These results suggest that these benzoquinoid ansamycin antibiotics, or closely related analogues, may offer a pharmacological means of increasing the level of heat shock proteins in cardiac tissue and thus protect the heart against ischemic/reperfusion injury.

References (0)

Cited by (56)

  • Celastrol-type HSP90 modulators allow for potent cardioprotective effects

    2019, Life Sciences
    Citation Excerpt :

    Modulation of HSP90 activity by celastrol is cardioprotective [10], nevertheless, other HSP90 modulators have conflicting results regarding cardioprotection. For instance the N-terminal modulator geldanamycin protects neonatal rat cardiomyocytes from ischemic stress following 4 h pretreatment [23], while inhibits ischemic preconditioning in vitro [17], cardiac ischemic postconditioning in vivo [24], and increases cellular damage when given at reperfusion in an ex vivo I/R model [25]. Similarly, 4 h pretreatment with radicicol protects neonatal rat cardiomyocytes from ischemia [26], yet short term (10 min) pre-treatment does not offer cardioprotection on an in vivo I/R model [27], demonstrating divergent responses of different HSP90 targeting molecules in the context of ischemia and ischemia/reperfusion injury.

  • Radicicol improves regeneration of skeletal muscle previously damaged by crotoxin in mice

    2008, Toxicon
    Citation Excerpt :

    Furthermore, HSPs contribute to several cellular processes, such as chaperoning proteins into degradation pathways as part of the ubiquitin proteasome system, maintaining the translocation-competent folding of endoplasmic reticulum and mitocondrial precursor proteins in the cytosol, and binding newly synthesized amino acid chains to ribosomes (Pilon and Schekman, 1999). In order to address the biological effects of HSPs, a series of compounds have been developed, including the benzoquinone ansamycin antibiotics geldanamycin and hebimycin A (Morris et al., 1996; Conde et al., 1997) and a more powerful compound, the antifungal macrocyclic antibiotic radicicol (Griffin et al., 2004), which are able to either disrupt the chaperone complex or inhibit a 90 kDa heat shock protein (HSP90). These compounds induce HSP expression by binding to HSP90, which regulates heat shock factor 1 (HSF1).

  • BGP-15 improves contractile function of regenerating soleus muscle

    2018, Journal of Muscle Research and Cell Motility
View all citing articles on Scopus

Please address all correspondence to: Ruben Mestril, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0618, USA.

View full text